63
Growth Score in past quarter
pts
Heat Score 63 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
680165
UGA Biopharma’s core area of business is the contract development of biologics and biosimilars.
- Lars Kober: CEO
About the Company
UGA Biopharma’s core area of business is the contract development of biologics and biosimilars. This involves all the necessary steps from cell line development and bioprocess development to the development of purification and analysis processes. UGA Biopharma’s unique selling feature is also that it offers its customers what are known as
ready-to-use biosimilar cell lines.